Get a glimpse into our company and investor data—powered by the PitchBook Platform
Developer of transformational stem cell therapy to treat diabetes. The company is developing stem cell-derived therapy for diabetes treatment and to eliminate a need for exogenous insulin.
This information is reserved for PitchBook Platform users. To explore Janssen (BetaLogics)‘s full profile, request access.
© 2020 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.